As a single mother, a new grandmother and emerging artist, Akaimi, 44, of San Antonio, TX, has an active and creative lifestyle. Her treatment for large granular lymphocytic leukemia was successful, and the cancer is now in remission, but she continues to have side effects from the chemo treatments. Her doctor recommended a biosimilar.
Not only did it work, but it saves me money too!Akaimi says.My copay is only $25. Now I have the energy and extra money to attend my art exhibits, respond to my Instagram fans and care for my family.
Savings from biosimilars for patients like Akaimi are projected to grow to $100 billion by 2025.
By Erica Klinger, Senior Director, Marketing
Published on May 14, 2021